Sort
51,593 grants matching “hepatitis”
Approaches to Cardiac Regeneration
$728,066Sylvia M Evans · University Of California, San Diego · DP1 · FY2013 · HL
Structural characterization of native HBV capsids and virions from human cells
$728,019Che-Yen Wang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · AI
Exosomal biomarkers for the early detection of hepatocellular carcinoma
$727,919Ajay Goel · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
The Epidemiology of the Weiss Cohort Project
$727,891Stanley H Weiss · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DA
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
$727,804David L Thomas · Johns Hopkins University · R01 · FY2019 · DA
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$727,729John A. Howard · Applied Biotechnology Institute · R44 · FY2014 · AI
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B
$727,689Stewart Cooper · California Pacific Med Ctr Res Institute · R01 · FY2022 · DK
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
$727,613Ramin Herati · New York University School Of Medicine · R01 · FY2021 · AI
Genomic Classification of Human Liver Cancer
$727,501Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Longitudinal evaluation of HIV-associated lung disease phenotypes
$727,478Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
HUMAN REQUIREMENTS FOR THE NUTRIENT CHOLINE
$727,449University Of North Carolina Chapel Hill · R01 · FY2003 · DK
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$727,400Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · HL
CONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC
$727,335Andrej Lyshchik · Thomas Jefferson University · R01 · FY2017 · CA
Longitudinal evaluation of HIV-associated lung disease phenotypes
$727,308Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Rhesus HHV-8 homologue in AIDS-related malignancies
$727,306Scott W Wong · Oregon Health & Science University · R01 · FY2018 · CA
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$727,222Frederick Lewis Altice · Yale University · R01 · FY2017 · DA
Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating
$727,078Ronald W. Helms · Rho Federal Systems Division, Inc. · U01 · FY2007 · HL
RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression
$726,936Carl A Latkin · Johns Hopkins University · R01 · FY2015 · DA
Studies of HCV Infection And HCV-Host interactions
$726,910T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Mechanisms of Insulin Resistance in Man
$726,860Rita Basu · University Of Virginia · R01 · FY2019 · DK
Coagulation Control To Protect Gaitko Lung and Liver Xenografts
$726,842Richard N Pierson · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI
A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment among Young Adult People who Inject Drugs
$726,713Meghan D Morris · University Of California, San Francisco · R01 · FY2022 · DA
Gluconeogenesis and Glycogenolysis - Role and Regulation
$726,704Alan D Cherrington · Vanderbilt University · R01 · FY2008 · DK
Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating
$726,645Ronald W. Helms · Rho Federal Systems Division, Inc. · U01 · FY2008 · HL
Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV
$726,542Suneil Krishna Koliwad · University Of California, San Francisco · R01 · FY2021 · DK